Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Roudnicky

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Angewandte Chemie (International Ed. in English)|September 14, 2013
Steering target selectivity and potency by fragment-based de novo drug designTiago Rodrigues, Takayuki Kudoh, Filip Roudnicky, et al.
The Journal of Pathology|March 16, 2017
High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survivalFilip Roudnicky, Lothar C Dieterich, Cedric Poyet, et al.
Stem Cell Reports|March 12, 2021
Decoding Neuronal Diversification by Multiplexed Single-cell RNA-SeqJoachim Luginbühl, Tsukasa Kouno, Rei Nakano, et al.
Molecular Therapy. Nucleic Acids|December 4, 2025
An unbiased whole-genome open reading frame overexpression screen identifies B3GALT2, a novel inducer of cellular ASO activityJulia Hesselmann, Carolina Hager, Liza Malong, et al.
Cancer Research|December 18, 2012
Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesisFilip Roudnicky, Cedric Poyet, Peter Wild, et al.
Journal of Clinical Pathology|August 8, 2015
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancerCédric Poyet, Lorenz Buser, Filip Roudnicky, et al.
Stem Cell Reports|February 21, 2025
An efficient, non-viral arrayed CRISPR screening platform for iPSC-derived myeloid and microglia modelsSonja Meier, Anne Sofie Gry Larsen, Florian Wanke, et al.
Oncogene|February 23, 2018
Alternative transcription of a shorter, non-anti-angiogenic thrombospondin-2 variant in cancer-associated blood vesselsFilip Roudnicky, Sun Young Yoon, Susanna Poghosyan, et al.
Molecular Neurobiology|July 23, 2025
Defining the Cis-Regulatory Elements of SCN1A in GABAergic InterneuronsJoachim Luginbühl, Anika V Prabhu, Chi Wai Yip, et al.
Nature Communications|May 30, 2026
Tunable gene control via RNA splicing with a clinically approved small moleculeMateusz Mendel, Dominic Schwarz, Tao Sun, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Angewandte Chemie (International Ed. in English)|September 14, 2013
Steering target selectivity and potency by fragment-based de novo drug designTiago Rodrigues, Takayuki Kudoh, Filip Roudnicky, et al.
The Journal of Pathology|March 16, 2017
High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survivalFilip Roudnicky, Lothar C Dieterich, Cedric Poyet, et al.
Stem Cell Reports|March 12, 2021
Decoding Neuronal Diversification by Multiplexed Single-cell RNA-SeqJoachim Luginbühl, Tsukasa Kouno, Rei Nakano, et al.
Molecular Therapy. Nucleic Acids|December 4, 2025
An unbiased whole-genome open reading frame overexpression screen identifies B3GALT2, a novel inducer of cellular ASO activityJulia Hesselmann, Carolina Hager, Liza Malong, et al.
Cancer Research|December 18, 2012
Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesisFilip Roudnicky, Cedric Poyet, Peter Wild, et al.
Journal of Clinical Pathology|August 8, 2015
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancerCédric Poyet, Lorenz Buser, Filip Roudnicky, et al.
Stem Cell Reports|February 21, 2025
An efficient, non-viral arrayed CRISPR screening platform for iPSC-derived myeloid and microglia modelsSonja Meier, Anne Sofie Gry Larsen, Florian Wanke, et al.
Oncogene|February 23, 2018
Alternative transcription of a shorter, non-anti-angiogenic thrombospondin-2 variant in cancer-associated blood vesselsFilip Roudnicky, Sun Young Yoon, Susanna Poghosyan, et al.
Molecular Neurobiology|July 23, 2025
Defining the Cis-Regulatory Elements of SCN1A in GABAergic InterneuronsJoachim Luginbühl, Anika V Prabhu, Chi Wai Yip, et al.
Nature Communications|May 30, 2026
Tunable gene control via RNA splicing with a clinically approved small moleculeMateusz Mendel, Dominic Schwarz, Tao Sun, et al.
Pageof 3